Latest news
UK ILAP Grants Innovation Passports to BeOne's Liver Cancer Therapy & CervoMed's Dementia Candidate - NAVLIN DAILYNAVLIN DAILY · Fri, 07 Aug 2026 08:42:41 GMTCervoMed granted Innovation Passport for neflamapimod in UK - The Pharma LetterThe Pharma Letter · Wed, 05 Aug 2026 13:17:34 GMTCervoMed to Share Drug Program Progress at Aug. 11 Chat - Stock TitanStock Titan · Wed, 05 Aug 2026 11:30:00 GMTInnovation Passports for Liver Cancer and Dementia Treatm... - politicsuk.compoliticsuk.com · Wed, 05 Aug 2026 08:04:23 GMTCervoMed’s neflamapimod gains UK Innovation Passport - TipRanksTipRanks · Tue, 04 Aug 2026 13:18:13 GMTCervoMed granted UK Innovation Passport for neflamapimod in dementia with Lewy bodies - TradingViewTradingView · Tue, 04 Aug 2026 11:53:00 GMTCervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB) - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 09:15:00 GMT